0001209191-17-056349.txt : 20171006
0001209191-17-056349.hdr.sgml : 20171006
20171006192640
ACCESSION NUMBER: 0001209191-17-056349
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171005
FILED AS OF DATE: 20171006
DATE AS OF CHANGE: 20171006
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barron Hal
CENTRAL INDEX KEY: 0001418677
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36781
FILM NUMBER: 171128350
MAIL ADDRESS:
STREET 1: 1 DNA WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Juno Therapeutics, Inc.
CENTRAL INDEX KEY: 0001594864
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463656275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 DEXTER AVENUE NORTH, SUITE 1200
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 2065821600
MAIL ADDRESS:
STREET 1: 400 DEXTER AVENUE NORTH, SUITE 1200
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-05
0
0001594864
Juno Therapeutics, Inc.
JUNO
0001418677
Barron Hal
C/O 400 DEXTER AVENUE NORTH
SUITE 1200
SEATTLE
WA
98109
1
0
0
0
Common Stock
2017-10-05
4
A
0
361
0.00
A
103444
D
Consists of fully vested restricted stock units.
/s/ Zachary D. Hale, attorney-in-fact
2017-10-06